These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Moxalactam therapy of difficult infections in patients with serious underlying conditions. Mogabgab WJ; Bauman DC; LaCorte WF; Pollock B; Pauling B; Beville RB; Holmes BJ J Int Med Res; 1983; 11(5):269-78. PubMed ID: 6642067 [TBL] [Abstract][Full Text] [Related]
5. The use of moxalactam in the treatment of serious infections due to multi-resistant organisms. Srinivasan S; Francke EL; Ortiz-Neu C; Prince AS; Neu HC Infection; 1983; 11(6):291-5. PubMed ID: 6668067 [TBL] [Abstract][Full Text] [Related]
7. [Clinical experience with moxalactam in the treatment of mixed aerobic-anaerobic surgical infections]. Gonzenbach HR; Sonnabend W Schweiz Rundsch Med Prax; 1983 Mar; 72(11):356-62. PubMed ID: 6221243 [No Abstract] [Full Text] [Related]
8. Cephalosporin therapy in intraabdominal infection: comparative studies of cefotetan, latamoxef and cefoxitin. Wilson SE J Chemother; 1989 Jul; 1(4 Suppl):820-2. PubMed ID: 16312655 [No Abstract] [Full Text] [Related]
9. Moxalactam therapy for bacterial infections. Winston DJ; Busuttil RW; Kurtz TO; Young LS Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253 [TBL] [Abstract][Full Text] [Related]
10. [The French experience with moxalactam in pneumology]. Leng B; Imbert Y; Coomans D Sem Hop; 1983 Jun; 59(26):1977-80. PubMed ID: 6310790 [TBL] [Abstract][Full Text] [Related]
11. Penetration of moxalactam into the cerebrospinal fluid and its application in therapy of bacterial meningitis. Cheng DL; Shi FW; Liu YC; Liu CY Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):634-8. PubMed ID: 3655708 [No Abstract] [Full Text] [Related]
12. [Moxalactam in complications of abdominal surgery]. Dupeyron JP; Peter JD; Rigolot JC Sem Hop; 1983 Jun; 59(26):1985-9. PubMed ID: 6310792 [TBL] [Abstract][Full Text] [Related]
13. [Latamoxef in resuscitation in acute renal failure. Measurement of plasma levels]. Carpentier F; Granier P; Croize J; Serre-Debeauvais F; Barnoud D; Guignier M Therapie; 1986; 41(6):487-92. PubMed ID: 3810544 [No Abstract] [Full Text] [Related]
14. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety. Stone HH; Kolb L; Geheber CE Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242 [No Abstract] [Full Text] [Related]
15. Twice-daily moxalactam versus gentamicin and clindamycin in patients with penetrating abdominal trauma. Crots LD; Obeid FN; Horst HM; Bivins BA Clin Pharm; 1985; 4(3):316-20. PubMed ID: 3891203 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics, in vitro activity and clinical experience with lamoxactam]. Klech H; Fiser I Schweiz Rundsch Med Prax; 1983 Mar; 72(11):369-78. PubMed ID: 6221244 [No Abstract] [Full Text] [Related]
17. Third-generation beta-lactam antibiotics for treatment of orthopedic infections. Mogabgab WJ; Haddad RJ; Longenecker SL; Buchanan TC; Johnston R; Macey TI; Bernard T; Floyd I Clin Ther; 1982; 5(1):21-43. PubMed ID: 7127366 [TBL] [Abstract][Full Text] [Related]
18. [Significance of the causative agent of infection for therapy of purulent peritonitis]. Wittmann DH; Teichmann W; Frommelt L Chirurg; 1985 Jun; 56(6):363-70. PubMed ID: 3896692 [No Abstract] [Full Text] [Related]